biphasic insulin aspart 30

Davies, M., Alibegovic, A. C., Anil, G., Braae, U. C., Jensen, A. B., & Nordsborg, R. B. (2023). Real-world study of the concomitant use of biphasic insulin as part 30/70 with GLP-1 receptor agonist versus first-generation basal insulin with GLP-1 receptor agonist in type 2 diabetes. Diabet Med, e15267. http://doi.org/10.1111/dme.15267

View